Middle-molecule uremic toxin removal via hemodialysis augmented with an immunosorbent packed bed

Industrial and Engineering Chemistry Research

Volumn 49, Issue 3, 2010, Pages 1359-1369

  Xia, Shu ^a   Hodge, Nichole ^a   Laski, Melvin ^b   Wiesner, Theodore F ^a  

^a Texas Tech University   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICES; HEMODIALYSIS PATIENT; HEMOPERFUSION; IMMUNOSORPTION; IN-VITRO; IN-VIVO; PARATHYROID HORMONES; PHARMACOKINETICS MODELS; SYNTHESIS RATE; TOXIN CONCENTRATIONS; UREMIC TOXINS;

DIALYSIS; HEMODIALYZERS; MATHEMATICAL MODELS; MOLECULES; PACKED BEDS;

DIALYSIS MEMBRANES;

EID: 76049089991     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie900597z     Document Type: Conference Paper

References (32)

1. Meyer, T. W.; Hostetter, T. H. Uremia. New Engl. J. Med. 2007, 357 (13), 1316-1325.
2. Winchester, J. F.; Audia, P. F. Extracorporeal strategies for the removal of middle molecules. Semin. Dial. 2006, 19 (2), 110-4.
3. Yavuz, A.; Tetta, C.; Ersoy, F. F.; D'Intini, V.; Ratanarat, R.; De Cal, M.; Bonello, M.; Bordoni, V.; Salvatori, G.; Andrikos, E.; Yakupoglu, G.; Levin, N. W.; Ronco, C. Uremic toxins: A new focus on an old subject. Semin. Dial. 2005, 18 (3), 203-211.
4. Foley, R. N.; Parfrey, P. S. Cardiovascular disease and mortality in ESRD. J. Nephrol. 1998, 11 (5), 239-45.
5. Bergstrom, J.; Lindholm, B. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Opinion. Semin. Dial. 2000, 13 (3), 163-164.
6. Winchester, J. F.; Ronco, C.; Brady, J. A.; Brendolan, A.; Davankov, V.; Tsyurupa, M.; Pavlova, L.; Pavlov, M.; Clemmer, J.; Polaschegg, H. D.; Muller, T. E.; La Greca, G.; Levin, N. W. Rationale for combined hemoperfusion/ hemodialysis in uremia. Contrib. Nephrol. 2001, (133), 174- 9.
7. Ronco, C.; Brendolan, A.; Winchester, J. F.; Golds, E.; Clemmer, J.; Polaschegg, H. D.; Muller, T. E.; Davankov, V.; Tsyurupa, M.; Pavlova, L.; Pavlov, M.; La Greca, G.; Levin, N. W. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Contrib. Nephrol. 2001, (133), 166-73.
8. Gejyo, F.; Kawaguchi, Y.; Hara, S.; Nakazawa, R.; Azuma, N.; Ogawa, H.; Koda, Y.; Suzuki, M.; Kaneda, H.; Kishimoto, H.; Oda, M.; Ei, K.; Miyazaki, R.; Maruyama, H.; Arakawa, M.; Hara, M. Arresting dialysis-related amyloidosis: A prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column. Artif. Organs 2004, 28 (4), 371-80.
9. Kellum, J. A.; Venkataraman, R.; Powner, D.; Elder, M.; Hergenroeder, G.; Carter, M. Feasibility study of cytokine removal by hemoadsorption in brain-dead humans. Crit. Care Med. 2008, 36 (1), 268-72.
10. Ullrich, H.; Kuehnl, P. New Trends in Specific Immunoadsorption. Transfus. Apheresis Sci. 2004, 30, 223-231.
11. Ameer, G. A.; Grovender, E. A.; Ploegh, H.; Ting, D.; Owen, W. F.; Rupnick, M.; Langer, R. A novel immunoadsorption device for removing beta2-microglobulin from whole blood. Kidney Int. 2001, 59 (4), 1544-50.
12. De Francisco, A. L.; Amado, J. A.; Prieto, M.; Alcalde, G.; Sanz de Castro, S.; Ruiz, J. C.; Morales, P.; Arias, M. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism. Nephron 1994, 66 (4), 442-6.
13. de Francisco, A. L. Secondary hyperparathyroidism: Review of the disease and its treatment. Clin. Ther. 2004, 26 (12), 1976-1993.
14. Hellman, P.; Backman, U.; Danielson, B. G.; Akerstrom, G.; Rastad, J.; Wide, L.; Ljunghall, S. Values of intact serum parathyroid hormone in different stages of renal insufficiency. Scand. J. Urol. Nephrol. 1991, 25 (3), 227-32.
15. Liu, J.; Liu, Z.; Tao, H. Effect of Blood Purification on Plasma Levels of Intact Parathyroid Hormone in Patients with Chronic Renal Failure. Acad. J. First Med. Coll. PLA 2004, 24 (2), 234-235.
16. Fournier, R. L. Basic Transport Phenomena in Biomedical Engineering; Taylor and Francis: Philadelphia, PA, 1999.
17. Lee, C. J.; Hsu, H. W.; Chang, Y. L. Performance Characteristics of Combined Haemodialysis/haemoperfusion System for Removal of Blood Toxins. Med. Eng. Phys. 1997, 19, 658-667.
18. Lauffenburger, D. A. A.; Linderman, J. J. A. Receptors: Models for Binding, Trafficking, and Signaling; Oxford University Press: New York, 1993.
19. Varma, A.; Morbidelli, M. Mathematical Methods in Chemical Engineering; Oxford University Press: New York, 1997; pp 365-372.
20. Skelland, A. H. P. Diffusional Mass Transfer; Robert E. Krieger Publishing Company: Malabar, FL, 1974.
21. Zlokarnik, M. Scale-up in Chemical Engineering; Wiley-VCH: Weinheim, Germany, 2002.
22. Botella, J.; Ghezzi, P. M.; Sanz-Moreno, C. Adsorption in hemodialysis. Kidney Int. 2000, 58, S60-S65.
23. Vanholder, R.; De Smet, R.; Glorieux, G.; Argiles, A.; Baurmeister, U.; Brunet, P.; Clark, W.; Cohen, G.; De Deyn, P. P.; Deppisch, R.; Descamps-Latscha, B.; Henle, T.; Jorres, A.; Lemke, H. D.; Massy, Z. A.; Passlick-Deetjen, J.; Rodriguez, M.; Stegmayr, B.; Stenvinkel, P.; Tetta, C.; Wanner, C.; Zidek, W. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 2003, 63 (5), 1934- 43.
24. Glassock, R. J. Uremic toxins: What are they? An integrated overview of pathobiology and classification. J. Renal Nutr. 2008, 18 (1), 2-6.
25. Schouten, W. E. M.; Grooteman, M. P. C.; van Houte, A. J.; Schoorl, M.; van Limbeek, J.; Nube, M. J. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol. Dial. Transplant. 2000, 15 (3), 379-384.
26. Pierratos, A. Effect of therapy time and frequency on effective solute removal. Semin. Dial. 2001, 14 (4), 284-288.
27. McFarlane, P. A.; Bayoumi, A. M.; Pierratos, A.; Redelmeier, D. A. The quality of life and cost utility of home nocturnal and conventional incenter hemodialysis. Kidney Int. 2003, 64 (3), 1004-1011.
28. Winchester, J. F.; Amerling, R.; Harbord, N.; Capponi, V.; Ronco, C. The potential application of sorbents in peritoneal dialysis. Contrib. Nephrol. 2006, 150, 336-43.
29. Momsen, G.; Schwarz, P. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium lowering in vivo. Scand. J. Clin. Lab. Invest. 1997, 57 (5), 381-94.
30. Pocotte, S. L.; Ehrenstein, G.; Fitzpatrick, L. A. Regulation of Parathyroid-Hormone Secretion. Endocr. Rev. 1991, 12 (3), 291-301.
31. Habener, J. F.; Potts, J. T. Chemistry, Biosynthesis, Secretion, and Metabolism of Parathyroid Hormone. In Handbook of Physiology; American Physiological Society: Bethesda, MD, 1976; Vol. 7 (Endocrinology), pp 313-342.
32. Ronco, C.; Ghezzi, P. M.; Morris, A.; Rosales, L.; Wang, E.; Zhu, F.; Metry, G.; De Simone, L.; Rhamati, S.; Adhikarla, R.; Bashir, A.; Manzoni, C.; Spittle, M.; Levin, N. W. Blood flow distribution in sorbent beds: Analysis of a new sorbent device for hemoperfusion. Int. J. Artif. Organs 2000, 23 (2), 125-30. (Pubitemid 30192768)